In silico Recombinant Vaccine Candidate against Coronavirus (2019-nCoV)

Designing a polytopic complex vaccine candidate against Gallibacterium anatis: an In-silico study

The haemolytic biovar of Gallibacterium anatis (G. anatis) is responsible for urogenital, gastrointestinal, and respiratory diseases in chickens. There are numerous reports on the resistance of G. anatis to antibiotics and recurrence of the disease, which raise concerns about antimicrobial treatment efficiency. Vaccination has been considered as the most feasibl...

Understanding the 2019-novel Coronavirus (2019-nCoV) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Review Study

Since December 2019, a new coronavirus, called the 2019-novel coronavirus (2019-nCoV), triggers pneumonia outbreak from Wuhan (Huanan seafood market) across China, which now poses major health threats to public health. The Corona Virus Disease-2019 (COVID-19) epidemic by 2019-nCoV is spreading worldwide, and by March 1, 2020, 67 countries, including Iran, have been affected. According to worldw...

New mutations causing the 2019 novel Coronavirus (2019-nCoV) epidemic: letter to the editor

No

New mutations causing the 2019 novel Coronavirus (2019-nCoV) epidemic: letter to the editor

[Full text in Persian]

New Coronavirus (2019-nCoV): An Insight Toward Preventive Actions and Natural Medicine